Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first1,941 to 1,960 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| CTH cystathionine gamma-lyase | 1491 HGNC:2501 | 1 | 71 | 0 | 0 | 1,059 | 3,417 |
| BTLA B and T lymphocyte associated | 151888 HGNC:21087 | 1 | 211 | 0 | 0 | 1,652 | 3,415 |
| BRD2 bromodomain containing 2 | 6046 HGNC:1103 | 1 | 110 | 6 | 42 | 2,589 | 3,414 |
| CALD1 caldesmon 1 | 800 HGNC:1441 | 1 | 26 | 0 | 0 | 1,614 | 3,413 |
| HCAR3 hydroxycarboxylic acid receptor 3 | 8843 HGNC:16824 | 1 | 18 | 0 | 0 | 2,075 | 3,413 |
| ATP1B1 ATPase Na+/K+ transporting subunit beta 1 | 481 HGNC:804 | 1 | 97 | 6 | 55 | 1,651 | 3,412 |
| MIR23B microRNA 23b | 407011 HGNC:31606 | 0 | 0 | 0 | 0 | 1,151 | 3,405 |
| SLC25A6 solute carrier family 25 member 6 | 293 HGNC:10992 | 1 | 45 | 0 | 0 | 1,986 | 3,401 |
| ABCB4 ATP binding cassette subfamily B member 4 | 5244 HGNC:45 | 1 | 35 | 0 | 0 | 1,715 | 3,400 |
| EXO1 exonuclease 1 | 9156 HGNC:3511 | 1 | 82 | 0 | 0 | 2,219 | 3,400 |
| TFE3 transcription factor binding to IGHM enhancer 3 | 7030 HGNC:11752 | 1 | 25 | 0 | 0 | 1,154 | 3,398 |
| CASP4 caspase 4 | 837 HGNC:1505 | 1 | 88 | 1 | 11 | 1,746 | 3,388 |
| HSPA9 heat shock protein family A (Hsp70) member 9 | 3313 HGNC:5244 | 1 | 121 | 0 | 0 | 1,948 | 3,383 |
| FSCN1 fascin actin-bundling protein 1 | 6624 HGNC:11148 | 1 | 44 | 0 | 0 | 1,500 | 3,382 |
| U2AF1 U2 small nuclear RNA auxiliary factor 1 | 7307 HGNC:12453 | 1 | 24 | 0 | 0 | 1,879 | 3,382 |
| MICB MHC class I polypeptide-related sequence B | 4277 HGNC:7091 | 1 | 46 | 0 | 0 | 2,015 | 3,381 |
| CD48 CD48 molecule | 962 HGNC:1683 | 1 | 97 | 0 | 0 | 2,184 | 3,378 |
| PRKD1 protein kinase D1 | 5587 HGNC:9407 | 1 | 62 | 6 | 71 | 2,521 | 3,376 |
| CFI complement factor I | 3426 HGNC:5394 | 1 | 94 | 0 | 0 | 1,574 | 3,374 |
| KLF5 KLF transcription factor 5 | 688 HGNC:6349 | 1 | 64 | 0 | 0 | 2,225 | 3,365 |
Code
curl "https://conductscience.org/api/genes/v1?page=98"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=98
{
"data": {
"total": 193990,
"results": [
{
"id": "1491",
"title": "CTH: cystathionine gamma-lyase",
"summary": "NCBI Gene 1491. 1 protein, 71 patents, 0 drugs, 0 trials, 1,059 NIH grants and 3,417 papers.",
"record": "/library/genes/1491",
"gene_id": 1491,
"symbol": "CTH",
"name": "cystathionine gamma-lyase",
"hgnc_id": "HGNC:2501",
"counts": {
"proteins": 1,
"patents": 71,
"drugs": 0,
"trials": 0,
"grants": 1059,
"papers": 3417
}
},
{
"id": "151888",
"title": "BTLA: B and T lymphocyte associated",
"summary": "NCBI Gene 151888. 1 protein, 211 patents, 0 drugs, 0 trials, 1,652 NIH grants and 3,415 papers.",
"record": "/library/genes/151888",
"gene_id": 151888,
"symbol": "BTLA",
"name": "B and T lymphocyte associated",
"hgnc_id": "HGNC:21087",
"counts": {
"proteins": 1,
"patents": 211,
"drugs": 0,
"trials": 0,
"grants": 1652,
"papers": 3415
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=99",
"request_id": "6xiZDn_0jRAz3S8p"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant